Da. Calhoun et al., Concentrations of granulocyte colony-stimulating factor in human milk after in vitro simulations of digestion, PEDIAT RES, 46(6), 1999, pp. 767-771
Human milk contains proteins that survive digestion in the neonatal gastroi
ntestinal tract. Our group and others have reported that granulocyte colony
-stimulating factor (G-CSF), a hematopoietic cytokine that influences neutr
ophil proliferation and differentiation, is present in human milk. We also
reported that specific receptors for G-CSF are expressed on the villous ent
erocytes of neonates. However, the physiologic role of milk-borne G-CSF is
not known. Thus, we sought to evaluate the capacity of human milk to protec
t G-CSF against proteolytic degradation after exposure to gastric secretion
s obtained from preterm (PT) and term (T) neonates at pH concentrations of
3.2, 5.8, and 7.4. Specifically, we examined degradation of 1) endogenous G
-CSF in PT (n = 15) and T (n = 15) human milk; 2) recombinant human G-CSF (
rhG-CSF) added to a protein-free buffer (n = 10, 5 PT and 5 T); and 3) rhG-
CSF added to human milk (n = 12, 6 PT and 6 T), various commercially prepar
ed infant formulas tit = 15), and cow's milli (n = 5). Endogenous G-CSF and
rhG-CSF added to human milk resisted degradation at 1 and 2 h. However, wh
en rhG-CSF was added to commercial formulas, >95% was degraded at 1 and 2 h
at each pH level. Similarly, approximately 60% of rhG-CSF added to cow's m
ilk was degraded at 1 and 2 h. We conclude that I) endogenous G-CSF and rhG
-CSF added to human milk are protected from degradation after exposure to g
astric secretions at physiologic pH levels, 2) rhG-CSF added to infant form
ulas is not protected from degradation, and 3) it is likely that the G-CSF
present in human milk is biologically available to the neonate.